Skip to main content
. 2020 Aug 15;19:185. doi: 10.1186/s12944-020-01363-y

Table 3.

Model results for the associations between sleep duration and each abnormal serum lipid level

Sleep duration (h) Event, n(%) Model 1 P value Model 2 P value Model 3 P value Sensitivity analysisa
HR(95% CI) HR(95% CI) HR(95% CI) HR(95% CI)
TC
 ≤ 5 902(43.34) 0.95(0.88–1.02) 0.170 0.95(0.88–1.02) 0.174 0.96(0.89–1.04) 0.331 0.99(0.90–1.10)
 6.0 2397(44.50) 1.00(0.94–1.06) 0.945 1.00(0.94–1.05) 0.893 1.00(0.95–1.06) 0.901 1.06(0.98–1.14)
 7.0 2520(44.81) reference reference reference reference
 8.0 8741(42.49) 0.93(0.89–0.97) 0.001 0.99(0.94–1.03) 0.527 0.99(0.94–1.04) 0.647 1.06(0.99–1.13)
 ≥ 9 237(39.83) 0.92(0.80–1.05) 0.216 0.92(0.81–1.05) 0.230 0.93(0.81–1.06) 0.278 0.98(0.83–1.16)
TG
 ≤ 5 555(26.67) 0.97(0.88–1.06) 0.495 0.96(0.87–1.05) 0.373 0.99(0.90–1.09) 0.795 1.03(0.91–1.17)
 6.0 1616(30.00) 1.04(0.97–1.11) 0.281 1.03(0.96–1.10) 0.413 1.03(0.97–1.11) 0.338 1.09(0.99–1.19)
 7.0 1702(30.26) reference reference reference reference
 8.0 6147(29.88) 1.01(0.96–1.06) 0.730 1.05(0.99–1.11) 0.094 1.04(0.98–1.10) 0.174 1.09(1.02–1.18)
 ≥ 9 188(31.60) 1.06(0.91–1.23) 0.445 1.07(0.92–1.24) 0.397 1.07(0.92–1.24) 0.406 1.08(0.89–1.31)
LDL-C
 ≤ 5 405(19.46) 1.03(0.92–1.15) 0.643 1.02 (0.91–1.14) 0.768 1.04(0.93–1.17) 0.515 1.07(0.93–1.23)
 6.0 1031(19.14) 1.03(0.94–1.12) 0.540 1.02(0.94–1.12) 0.584 1.03(0.94–1.12) 0.532 1.08(0.98–1.21)
 7.0 1035(18.40) reference reference reference reference
 8.0 4269(20.75) 1.18(1.10–1.26) < 0.001 1.20(1.12–30) < 0.001 1.21(1.12–1.30) < 0.001 1.25(1.14–1.36)
 ≥ 9 100(16.81) 1.00(0.81–1.22) 0.969 0.99(0.81–1.22) 0.952 1.00(0.81–1.23) 0.985 0.88(0.67–1.14)
HDL-C
 ≤ 5 1482(71.22) 1.01(0.95–1.07) 0.779 1.01(0.95–1.08) 0.655 1.02(0.96–1.08) 0.605 1.02(0.95–1.09)
 6.0 3658(67.90) 1.01(0.97–1.06) 0.570 1.02(0.97–1.06) 0.505 1.01(0.97–1.06) 0.579 1.02(0.96–1.07)
 7.0 3638(64.69) reference reference reference reference
 8.0 13,610(66.15) 1.11(1.07–1.16) < 0.001 1.11(1.07–1.15) < 0.001 1.10(1.06–1.15) < 0.001 1.11(1.06–1.16)
 ≥ 9 412(69.24) 1.27(1.15–1.41) < 0.001 1.27(1.14–1.40) < 0.001 1.24(1.12–1.38) < 0.001 1.21(1.07–1.35)
Dyslipidemia
 ≤ 5 1298(62.37) 0.96(0.90–1.02) 0.166 0.96(0.90–1.02) 0.955 0.98(0.92–1.04) 0.471 0.99(0.92–1.08)
 6.0 3558(66.05) 1.04(0.99–1.10) 0.061 1.04(0.99–1.10) 0.061 1.05(1.00–1.10) 0.036 1.07(1.01–1.14)
 7.0 3695(65.70) reference reference reference reference
 8.0 13,081(63.58) 0.95(0.92–0.99) 0.012 1.01(0.97–1.05) 0.564 1.01(0.97–1.05) 0.509 1.08(1.02–1.14)
 ≥ 9 379(63.70) 0.98(0.88–1.09) 0.681 0.98(0.88–1.09) 0.706 0.98(0.88–1.09) 0.685 1.08(0.95–1.24)

Model 1 adjusted for age and sex

Model 2 was further adjusted for level of education, smoking, alcohol, physical activity, and snoring. Model 3 was further adjusted for hypertension, diabetes mellitus, body mass index, and high-sensitivity C-reactive protein

a Adjusted for model 3 and further excluded individuals with transient changes in lipid profile (e.g., reversion from dyslipidemia to normal blood lipid)